Fbxl8 suppresses lymphoma growth and hematopoietic transformation through degradation of cyclin D3
Open Access
- 29 October 2020
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 40 (2) , 292-306
Abstract
Overexpression of D-type cyclins in human cancer frequently occurs as a result of protein stabilization, emphasizing the importance of identification of the machinery that regulates their ubiqutin-dependent degradation. Cyclin D3 is overexpressed in ~50% of Burkitt’s lymphoma correlating with a mutation of Thr-283. However, the E3 ligase that regulates phosphorylated cyclin D3 and whether a stabilized, phosphorylation deficient mutant of cyclin D3, has oncogenic activity are undefined. We describe the identification of SCF-Fbxl8 as the E3 ligase for Thr-283 phosphorylated cyclin D3. SCF-Fbxl8 poly-ubiquitylates p-Thr-283 cyclin D3 targeting it to the proteasome. Functional investigation demonstrates that Fbxl8 antagonizes cell cycle progression, hematopoietic cell proliferation, and oncogene-induced transformation through degradation of cyclin D3, which is abolished by expression of cyclin D3T283A, a non-phosphorylatable mutant. Clinically, the expression of cyclin D3 is inversely correlated with the expression of Fbxl8 in lymphomas from human patients implicating Fbxl8 functions as a tumor suppressor.Keywords
Funding Information
- U.S. Department of Health & Human Services | National Institutes of Health (R01CA093237, P01098101)
- U.S. Department of Health & Human Services | National Institutes of Health
This publication has 31 references indexed in Scilit:
- Therapeutic Targeting of the Cyclin D3:CDK4/6 Complex in T Cell LeukemiaCancer Cell, 2012
- F-box protein FBXL2 targets cyclin D2 for ubiquitination and degradation to inhibit leukemic cell proliferationBlood, 2012
- The Fbx4 Tumor Suppressor Regulates Cyclin D1 Accumulation and Prevents Neoplastic TransformationMolecular and Cellular Biology, 2011
- A Systematic Screen for CDK4/6 Substrates Links FOXM1 Phosphorylation to Senescence Suppression in Cancer CellsCancer Cell, 2011
- F-box protein FBXL2 exerts human lung tumor suppressor-like activity by ubiquitin-mediated degradation of cyclin D3 resulting in cell cycle arrestOncogene, 2011
- Nuclear Cyclin D1/CDK4 Kinase Regulates CUL4 Expression and Triggers Neoplastic Growth via Activation of the PRMT5 MethyltransferaseCancer Cell, 2010
- Nuclear cyclin D1: An oncogenic driver in human cancerJournal of Cellular Physiology, 2009
- Nuclear accumulation of cyclin D1 during S phase inhibits Cul4-dependent Cdt1 proteolysis and triggers p53-dependent DNA rereplicationGenes & Development, 2007
- Phosphorylation-Dependent Ubiquitination of Cyclin D1 by the SCFFBX4-αB Crystallin ComplexMolecular Cell, 2006
- Expression of constitutively nuclear cyclin D1 in murine lymphocytes induces B-cell lymphomaOncogene, 2005